ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)

Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 17 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics

Intellia Therapeutics Opened at 9.13 and Closed at: 8.79, which is -3.75% of previous session's close. It moved within a range of 8.78 and 9.55
The session was a Bearish session with an average volume of 3282000, which is 23.83% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

A Golden cross was found 8 days back on short term averages

Support for tomorrow is 8.4 and resistance for tomorrow is 9.17
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 8.53, 8.27 resistance for tomorrow's hourly charts is 9.3, 9.81

10 Day SMA for Intellia Therapeutics (NTLA) is 9.31 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Intellia Therapeutics (NTLA) is 8.88 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Intellia Therapeutics (NTLA) is 13.94 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 13.58 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Intellia Therapeutics is 11.29 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Intellia Therapeutics is at 8.88 and 200 DMA is at 11.29, while 50 DMA and 100 DMA are at 13.94 and 13.58 respectively

Intellia Therapeutics (NTLA) moving average of 20 SMA is at 8.88 and 20 EMA is at 9.53

Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.94 and 50 EMA is at 11.6

Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.58 and 100 EMA is at 12.5

Intellia Therapeutics (NTLA) moving average of 200 SMA is at 11.29 and 200 EMA is at 13.03

Intellia Therapeutics has performed better than Vistagen Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Veru Inc in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Urogen Pharma in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Si Bone in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Phio Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!

Livanova Plc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 10.34% more returns!

Intellia Therapeutics has performed better than Irhythm Technologies in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Insmed Inc in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Guardant Health in short term. Holding Intellia Therapeutics could be a better choice for now!

Geron Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Geron Corporation, about 22.96% more returns!

Intellia Therapeutics has performed better than Fibrogen Inc in short term. Holding Intellia Therapeutics could be a better choice for now!

Fortress Biotech has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Fortress Biotech, about 24.87% more returns!

Intellia Therapeutics has performed better than Curis Inc in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Corbus Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics has performed better than Celldex Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!

Intellia Therapeutics Technical analysis of indicators

Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Intellia Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 9.33 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.

Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NTLA Experts View which covers a lot of information including buying and selling signals

NTLA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here

Chart Intellia Therapeutics (NTLA)  Technical (Analysis) Reports Intellia Therapeutics [

Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Intellia Therapeutics (NTLA)  Technical (Analysis) Reports Intellia Therapeutics [

 

Back to top